nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—CYP2C19—Vismodegib—skin cancer	0.0527	1	CbGbCtD
Famotidine—Shock—Imiquimod—skin cancer	0.00266	0.00281	CcSEcCtD
Famotidine—Upper respiratory tract infection—Temozolomide—skin cancer	0.00265	0.0028	CcSEcCtD
Famotidine—Pollakiuria—Temozolomide—skin cancer	0.00264	0.00278	CcSEcCtD
Famotidine—Erectile dysfunction—Temozolomide—skin cancer	0.00263	0.00278	CcSEcCtD
Famotidine—Agranulocytosis—Dactinomycin—skin cancer	0.00263	0.00277	CcSEcCtD
Famotidine—Photosensitivity reaction—Temozolomide—skin cancer	0.00261	0.00275	CcSEcCtD
Famotidine—Anorexia—Imiquimod—skin cancer	0.00258	0.00273	CcSEcCtD
Famotidine—Depression—Temozolomide—skin cancer	0.00254	0.00268	CcSEcCtD
Famotidine—Hepatitis—Dactinomycin—skin cancer	0.00253	0.00267	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00252	0.00266	CcSEcCtD
Famotidine—Flushing—Bleomycin—skin cancer	0.00251	0.00265	CcSEcCtD
Famotidine—Body temperature increased—Vemurafenib—skin cancer	0.00251	0.00265	CcSEcCtD
Famotidine—Pharyngitis—Dactinomycin—skin cancer	0.00251	0.00265	CcSEcCtD
Famotidine—Pancytopenia—Fluorouracil—skin cancer	0.0025	0.00264	CcSEcCtD
Famotidine—Swelling—Docetaxel—skin cancer	0.00249	0.00263	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00247	0.00261	CcSEcCtD
Famotidine—Insomnia—Imiquimod—skin cancer	0.00245	0.00259	CcSEcCtD
Famotidine—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00244	0.00258	CcSEcCtD
Famotidine—Paraesthesia—Imiquimod—skin cancer	0.00243	0.00257	CcSEcCtD
Famotidine—Somnolence—Imiquimod—skin cancer	0.00241	0.00254	CcSEcCtD
Famotidine—Photosensitivity reaction—Fluorouracil—skin cancer	0.0024	0.00253	CcSEcCtD
Famotidine—Alopecia—Bleomycin—skin cancer	0.00239	0.00253	CcSEcCtD
Famotidine—Erythema multiforme—Dactinomycin—skin cancer	0.00239	0.00252	CcSEcCtD
Famotidine—Sinusitis—Temozolomide—skin cancer	0.00239	0.00252	CcSEcCtD
Famotidine—Dyspepsia—Imiquimod—skin cancer	0.00238	0.00252	CcSEcCtD
Famotidine—Decreased appetite—Imiquimod—skin cancer	0.00235	0.00249	CcSEcCtD
Famotidine—Flushing—Dactinomycin—skin cancer	0.00234	0.00247	CcSEcCtD
Famotidine—Hypersensitivity—Vemurafenib—skin cancer	0.00234	0.00247	CcSEcCtD
Famotidine—Fatigue—Imiquimod—skin cancer	0.00234	0.00247	CcSEcCtD
Famotidine—Pain—Imiquimod—skin cancer	0.00232	0.00245	CcSEcCtD
Famotidine—Hepatitis—Temozolomide—skin cancer	0.00228	0.00241	CcSEcCtD
Famotidine—Asthenia—Vemurafenib—skin cancer	0.00228	0.00241	CcSEcCtD
Famotidine—Hallucination—Temozolomide—skin cancer	0.00227	0.0024	CcSEcCtD
Famotidine—Pharyngitis—Temozolomide—skin cancer	0.00227	0.00239	CcSEcCtD
Famotidine—Pruritus—Vemurafenib—skin cancer	0.00225	0.00237	CcSEcCtD
Famotidine—Alopecia—Dactinomycin—skin cancer	0.00223	0.00236	CcSEcCtD
Famotidine—Feeling abnormal—Imiquimod—skin cancer	0.00223	0.00236	CcSEcCtD
Famotidine—Gastrointestinal pain—Imiquimod—skin cancer	0.00221	0.00234	CcSEcCtD
Famotidine—Sinusitis—Fluorouracil—skin cancer	0.0022	0.00232	CcSEcCtD
Famotidine—Pain in extremity—Docetaxel—skin cancer	0.0022	0.00232	CcSEcCtD
Famotidine—Agranulocytosis—Fluorouracil—skin cancer	0.00219	0.00231	CcSEcCtD
Famotidine—Anaemia—Bleomycin—skin cancer	0.00218	0.0023	CcSEcCtD
Famotidine—Diarrhoea—Vemurafenib—skin cancer	0.00217	0.00229	CcSEcCtD
Famotidine—Migraine—Docetaxel—skin cancer	0.00216	0.00228	CcSEcCtD
Famotidine—Erythema multiforme—Temozolomide—skin cancer	0.00216	0.00228	CcSEcCtD
Famotidine—Urticaria—Imiquimod—skin cancer	0.00215	0.00227	CcSEcCtD
Famotidine—Abdominal pain—Imiquimod—skin cancer	0.00214	0.00226	CcSEcCtD
Famotidine—Body temperature increased—Imiquimod—skin cancer	0.00214	0.00226	CcSEcCtD
Famotidine—Tinnitus—Temozolomide—skin cancer	0.00213	0.00225	CcSEcCtD
Famotidine—Flushing—Temozolomide—skin cancer	0.00212	0.00224	CcSEcCtD
Famotidine—Leukopenia—Bleomycin—skin cancer	0.00211	0.00223	CcSEcCtD
Famotidine—Dizziness—Vemurafenib—skin cancer	0.0021	0.00222	CcSEcCtD
Famotidine—Pharyngitis—Fluorouracil—skin cancer	0.00209	0.00221	CcSEcCtD
Famotidine—Cough—Bleomycin—skin cancer	0.00206	0.00217	CcSEcCtD
Famotidine—Anaemia—Dactinomycin—skin cancer	0.00203	0.00215	CcSEcCtD
Famotidine—Vomiting—Vemurafenib—skin cancer	0.00202	0.00213	CcSEcCtD
Famotidine—Alopecia—Temozolomide—skin cancer	0.00202	0.00213	CcSEcCtD
Famotidine—Dry skin—Docetaxel—skin cancer	0.00201	0.00213	CcSEcCtD
Famotidine—Chest pain—Bleomycin—skin cancer	0.00201	0.00212	CcSEcCtD
Famotidine—Myalgia—Bleomycin—skin cancer	0.00201	0.00212	CcSEcCtD
Famotidine—Rash—Vemurafenib—skin cancer	0.002	0.00211	CcSEcCtD
Famotidine—Mental disorder—Temozolomide—skin cancer	0.002	0.00211	CcSEcCtD
Famotidine—Dermatitis—Vemurafenib—skin cancer	0.002	0.00211	CcSEcCtD
Famotidine—Hypersensitivity—Imiquimod—skin cancer	0.002	0.00211	CcSEcCtD
Famotidine—Headache—Vemurafenib—skin cancer	0.00199	0.0021	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00198	0.00209	CcSEcCtD
Famotidine—Cramp muscle—Docetaxel—skin cancer	0.00198	0.00209	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00198	0.00209	CcSEcCtD
Famotidine—Leukopenia—Dactinomycin—skin cancer	0.00197	0.00208	CcSEcCtD
Famotidine—Dysgeusia—Temozolomide—skin cancer	0.00195	0.00206	CcSEcCtD
Famotidine—Asthenia—Imiquimod—skin cancer	0.00194	0.00205	CcSEcCtD
Famotidine—Confusional state—Bleomycin—skin cancer	0.00194	0.00205	CcSEcCtD
Famotidine—Anaphylactic shock—Bleomycin—skin cancer	0.00192	0.00203	CcSEcCtD
Famotidine—Oedema—Bleomycin—skin cancer	0.00192	0.00203	CcSEcCtD
Famotidine—Back pain—Temozolomide—skin cancer	0.00192	0.00203	CcSEcCtD
Famotidine—Pruritus—Imiquimod—skin cancer	0.00192	0.00202	CcSEcCtD
Famotidine—Infection—Bleomycin—skin cancer	0.00191	0.00202	CcSEcCtD
Famotidine—Nausea—Vemurafenib—skin cancer	0.00189	0.00199	CcSEcCtD
Famotidine—Thrombocytopenia—Bleomycin—skin cancer	0.00188	0.00199	CcSEcCtD
Famotidine—Arrhythmia—Fluorouracil—skin cancer	0.00188	0.00199	CcSEcCtD
Famotidine—Myalgia—Dactinomycin—skin cancer	0.00187	0.00198	CcSEcCtD
Famotidine—Bronchospasm—Docetaxel—skin cancer	0.00187	0.00197	CcSEcCtD
Famotidine—Alopecia—Fluorouracil—skin cancer	0.00186	0.00196	CcSEcCtD
Famotidine—Diarrhoea—Imiquimod—skin cancer	0.00185	0.00196	CcSEcCtD
Famotidine—Anaemia—Temozolomide—skin cancer	0.00184	0.00194	CcSEcCtD
Famotidine—Anorexia—Bleomycin—skin cancer	0.00183	0.00194	CcSEcCtD
Famotidine—Agitation—Temozolomide—skin cancer	0.00183	0.00193	CcSEcCtD
Famotidine—Angioedema—Temozolomide—skin cancer	0.00182	0.00192	CcSEcCtD
Famotidine—Pancytopenia—Docetaxel—skin cancer	0.0018	0.0019	CcSEcCtD
Famotidine—Oedema—Dactinomycin—skin cancer	0.00179	0.00189	CcSEcCtD
Famotidine—Dizziness—Imiquimod—skin cancer	0.00179	0.00189	CcSEcCtD
Famotidine—Infection—Dactinomycin—skin cancer	0.00178	0.00188	CcSEcCtD
Famotidine—Leukopenia—Temozolomide—skin cancer	0.00178	0.00188	CcSEcCtD
Famotidine—Neutropenia—Docetaxel—skin cancer	0.00178	0.00187	CcSEcCtD
Famotidine—Palpitations—Temozolomide—skin cancer	0.00176	0.00186	CcSEcCtD
Famotidine—Thrombocytopenia—Dactinomycin—skin cancer	0.00176	0.00185	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00175	0.00185	CcSEcCtD
Famotidine—Cough—Temozolomide—skin cancer	0.00174	0.00183	CcSEcCtD
Famotidine—Paraesthesia—Bleomycin—skin cancer	0.00173	0.00182	CcSEcCtD
Famotidine—Convulsion—Temozolomide—skin cancer	0.00172	0.00182	CcSEcCtD
Famotidine—Vomiting—Imiquimod—skin cancer	0.00172	0.00182	CcSEcCtD
Famotidine—Anorexia—Dactinomycin—skin cancer	0.00171	0.00181	CcSEcCtD
Famotidine—Rash—Imiquimod—skin cancer	0.00171	0.0018	CcSEcCtD
Famotidine—Dermatitis—Imiquimod—skin cancer	0.00171	0.0018	CcSEcCtD
Famotidine—Headache—Imiquimod—skin cancer	0.0017	0.00179	CcSEcCtD
Famotidine—Anaemia—Fluorouracil—skin cancer	0.00169	0.00179	CcSEcCtD
Famotidine—Myalgia—Temozolomide—skin cancer	0.00169	0.00179	CcSEcCtD
Famotidine—Arthralgia—Temozolomide—skin cancer	0.00169	0.00179	CcSEcCtD
Famotidine—Anxiety—Temozolomide—skin cancer	0.00169	0.00178	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00168	0.00177	CcSEcCtD
Famotidine—Decreased appetite—Bleomycin—skin cancer	0.00167	0.00177	CcSEcCtD
Famotidine—Dry mouth—Temozolomide—skin cancer	0.00166	0.00175	CcSEcCtD
Famotidine—Jaundice—Docetaxel—skin cancer	0.00165	0.00174	CcSEcCtD
Famotidine—Pain—Bleomycin—skin cancer	0.00165	0.00174	CcSEcCtD
Famotidine—Leukopenia—Fluorouracil—skin cancer	0.00164	0.00173	CcSEcCtD
Famotidine—Confusional state—Temozolomide—skin cancer	0.00164	0.00173	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00164	0.00173	CcSEcCtD
Famotidine—Anaphylactic shock—Temozolomide—skin cancer	0.00162	0.00171	CcSEcCtD
Famotidine—Oedema—Temozolomide—skin cancer	0.00162	0.00171	CcSEcCtD
Famotidine—Infection—Temozolomide—skin cancer	0.00161	0.0017	CcSEcCtD
Famotidine—Nausea—Imiquimod—skin cancer	0.00161	0.0017	CcSEcCtD
Famotidine—Thrombocytopenia—Temozolomide—skin cancer	0.00159	0.00168	CcSEcCtD
Famotidine—Convulsion—Fluorouracil—skin cancer	0.00159	0.00168	CcSEcCtD
Famotidine—Feeling abnormal—Bleomycin—skin cancer	0.00159	0.00167	CcSEcCtD
Famotidine—Agranulocytosis—Docetaxel—skin cancer	0.00158	0.00167	CcSEcCtD
Famotidine—Chest pain—Fluorouracil—skin cancer	0.00156	0.00165	CcSEcCtD
Famotidine—Myalgia—Fluorouracil—skin cancer	0.00156	0.00165	CcSEcCtD
Famotidine—Decreased appetite—Dactinomycin—skin cancer	0.00156	0.00165	CcSEcCtD
Famotidine—Fatigue—Dactinomycin—skin cancer	0.00155	0.00163	CcSEcCtD
Famotidine—Anorexia—Temozolomide—skin cancer	0.00155	0.00163	CcSEcCtD
Famotidine—Pain—Dactinomycin—skin cancer	0.00153	0.00162	CcSEcCtD
Famotidine—Urticaria—Bleomycin—skin cancer	0.00153	0.00161	CcSEcCtD
Famotidine—Body temperature increased—Bleomycin—skin cancer	0.00152	0.00161	CcSEcCtD
Famotidine—Hepatitis—Docetaxel—skin cancer	0.00152	0.0016	CcSEcCtD
Famotidine—Confusional state—Fluorouracil—skin cancer	0.00151	0.00159	CcSEcCtD
Famotidine—Pharyngitis—Docetaxel—skin cancer	0.00151	0.00159	CcSEcCtD
Famotidine—Oedema—Fluorouracil—skin cancer	0.0015	0.00158	CcSEcCtD
Famotidine—Anaphylactic shock—Fluorouracil—skin cancer	0.0015	0.00158	CcSEcCtD
Famotidine—Infection—Fluorouracil—skin cancer	0.00149	0.00157	CcSEcCtD
Famotidine—Feeling abnormal—Dactinomycin—skin cancer	0.00148	0.00156	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00148	0.00156	CcSEcCtD
Famotidine—Insomnia—Temozolomide—skin cancer	0.00147	0.00155	CcSEcCtD
Famotidine—Gastrointestinal pain—Dactinomycin—skin cancer	0.00147	0.00155	CcSEcCtD
Famotidine—Thrombocytopenia—Fluorouracil—skin cancer	0.00146	0.00155	CcSEcCtD
Famotidine—Paraesthesia—Temozolomide—skin cancer	0.00146	0.00154	CcSEcCtD
Famotidine—Somnolence—Temozolomide—skin cancer	0.00144	0.00152	CcSEcCtD
Famotidine—Erythema multiforme—Docetaxel—skin cancer	0.00144	0.00152	CcSEcCtD
Famotidine—Dyspepsia—Temozolomide—skin cancer	0.00143	0.00151	CcSEcCtD
Famotidine—Anorexia—Fluorouracil—skin cancer	0.00143	0.0015	CcSEcCtD
Famotidine—Abdominal pain—Dactinomycin—skin cancer	0.00142	0.0015	CcSEcCtD
Famotidine—Body temperature increased—Dactinomycin—skin cancer	0.00142	0.0015	CcSEcCtD
Famotidine—Hypersensitivity—Bleomycin—skin cancer	0.00142	0.0015	CcSEcCtD
Famotidine—Decreased appetite—Temozolomide—skin cancer	0.00141	0.00149	CcSEcCtD
Famotidine—Flushing—Docetaxel—skin cancer	0.00141	0.00149	CcSEcCtD
Famotidine—Fatigue—Temozolomide—skin cancer	0.0014	0.00148	CcSEcCtD
Famotidine—Pain—Temozolomide—skin cancer	0.00139	0.00147	CcSEcCtD
Famotidine—Constipation—Temozolomide—skin cancer	0.00139	0.00147	CcSEcCtD
Famotidine—Asthenia—Bleomycin—skin cancer	0.00138	0.00146	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00136	0.00144	CcSEcCtD
Famotidine—Pruritus—Bleomycin—skin cancer	0.00136	0.00144	CcSEcCtD
Famotidine—Arrhythmia—Docetaxel—skin cancer	0.00136	0.00143	CcSEcCtD
Famotidine—Insomnia—Fluorouracil—skin cancer	0.00135	0.00143	CcSEcCtD
Famotidine—Paraesthesia—Fluorouracil—skin cancer	0.00134	0.00142	CcSEcCtD
Famotidine—Alopecia—Docetaxel—skin cancer	0.00134	0.00142	CcSEcCtD
Famotidine—Feeling abnormal—Temozolomide—skin cancer	0.00134	0.00141	CcSEcCtD
Famotidine—Mental disorder—Docetaxel—skin cancer	0.00133	0.00141	CcSEcCtD
Famotidine—Somnolence—Fluorouracil—skin cancer	0.00133	0.0014	CcSEcCtD
Famotidine—Gastrointestinal pain—Temozolomide—skin cancer	0.00133	0.0014	CcSEcCtD
Famotidine—Hypersensitivity—Dactinomycin—skin cancer	0.00132	0.0014	CcSEcCtD
Famotidine—Dyspepsia—Fluorouracil—skin cancer	0.00132	0.00139	CcSEcCtD
Famotidine—Decreased appetite—Fluorouracil—skin cancer	0.0013	0.00137	CcSEcCtD
Famotidine—Dysgeusia—Docetaxel—skin cancer	0.0013	0.00137	CcSEcCtD
Famotidine—Urticaria—Temozolomide—skin cancer	0.00129	0.00136	CcSEcCtD
Famotidine—Asthenia—Dactinomycin—skin cancer	0.00129	0.00136	CcSEcCtD
Famotidine—Abdominal pain—Temozolomide—skin cancer	0.00128	0.00135	CcSEcCtD
Famotidine—Body temperature increased—Temozolomide—skin cancer	0.00128	0.00135	CcSEcCtD
Famotidine—Back pain—Docetaxel—skin cancer	0.00128	0.00135	CcSEcCtD
Famotidine—Pain—Fluorouracil—skin cancer	0.00128	0.00135	CcSEcCtD
Famotidine—Muscle spasms—Docetaxel—skin cancer	0.00127	0.00134	CcSEcCtD
Famotidine—Feeling abnormal—Fluorouracil—skin cancer	0.00123	0.0013	CcSEcCtD
Famotidine—Diarrhoea—Dactinomycin—skin cancer	0.00123	0.0013	CcSEcCtD
Famotidine—Vomiting—Bleomycin—skin cancer	0.00122	0.00129	CcSEcCtD
Famotidine—Anaemia—Docetaxel—skin cancer	0.00122	0.00129	CcSEcCtD
Famotidine—Rash—Bleomycin—skin cancer	0.00121	0.00128	CcSEcCtD
Famotidine—Dermatitis—Bleomycin—skin cancer	0.00121	0.00128	CcSEcCtD
Famotidine—Hypersensitivity—Temozolomide—skin cancer	0.0012	0.00126	CcSEcCtD
Famotidine—Urticaria—Fluorouracil—skin cancer	0.00119	0.00125	CcSEcCtD
Famotidine—Syncope—Docetaxel—skin cancer	0.00119	0.00125	CcSEcCtD
Famotidine—Leukopenia—Docetaxel—skin cancer	0.00118	0.00125	CcSEcCtD
Famotidine—Body temperature increased—Fluorouracil—skin cancer	0.00118	0.00125	CcSEcCtD
Famotidine—Palpitations—Docetaxel—skin cancer	0.00117	0.00123	CcSEcCtD
Famotidine—Asthenia—Temozolomide—skin cancer	0.00116	0.00123	CcSEcCtD
Famotidine—Loss of consciousness—Docetaxel—skin cancer	0.00116	0.00123	CcSEcCtD
Famotidine—Cough—Docetaxel—skin cancer	0.00115	0.00122	CcSEcCtD
Famotidine—Pruritus—Temozolomide—skin cancer	0.00115	0.00121	CcSEcCtD
Famotidine—Convulsion—Docetaxel—skin cancer	0.00115	0.00121	CcSEcCtD
Famotidine—Nausea—Bleomycin—skin cancer	0.00114	0.00121	CcSEcCtD
Famotidine—Vomiting—Dactinomycin—skin cancer	0.00114	0.0012	CcSEcCtD
Famotidine—Rash—Dactinomycin—skin cancer	0.00113	0.00119	CcSEcCtD
Famotidine—Myalgia—Docetaxel—skin cancer	0.00113	0.00119	CcSEcCtD
Famotidine—Arthralgia—Docetaxel—skin cancer	0.00113	0.00119	CcSEcCtD
Famotidine—Chest pain—Docetaxel—skin cancer	0.00113	0.00119	CcSEcCtD
Famotidine—Diarrhoea—Temozolomide—skin cancer	0.00111	0.00117	CcSEcCtD
Famotidine—Hypersensitivity—Fluorouracil—skin cancer	0.0011	0.00116	CcSEcCtD
Famotidine—Dry mouth—Docetaxel—skin cancer	0.0011	0.00116	CcSEcCtD
Famotidine—Confusional state—Docetaxel—skin cancer	0.00109	0.00115	CcSEcCtD
Famotidine—Oedema—Docetaxel—skin cancer	0.00108	0.00114	CcSEcCtD
Famotidine—Anaphylactic shock—Docetaxel—skin cancer	0.00108	0.00114	CcSEcCtD
Famotidine—Dizziness—Temozolomide—skin cancer	0.00107	0.00113	CcSEcCtD
Famotidine—Infection—Docetaxel—skin cancer	0.00107	0.00113	CcSEcCtD
Famotidine—Nausea—Dactinomycin—skin cancer	0.00107	0.00113	CcSEcCtD
Famotidine—Shock—Docetaxel—skin cancer	0.00106	0.00112	CcSEcCtD
Famotidine—Pruritus—Fluorouracil—skin cancer	0.00106	0.00112	CcSEcCtD
Famotidine—Thrombocytopenia—Docetaxel—skin cancer	0.00106	0.00112	CcSEcCtD
Famotidine—Vomiting—Temozolomide—skin cancer	0.00103	0.00109	CcSEcCtD
Famotidine—Anorexia—Docetaxel—skin cancer	0.00103	0.00109	CcSEcCtD
Famotidine—Rash—Temozolomide—skin cancer	0.00102	0.00108	CcSEcCtD
Famotidine—Diarrhoea—Fluorouracil—skin cancer	0.00102	0.00108	CcSEcCtD
Famotidine—Dermatitis—Temozolomide—skin cancer	0.00102	0.00108	CcSEcCtD
Famotidine—Headache—Temozolomide—skin cancer	0.00102	0.00107	CcSEcCtD
Famotidine—Dizziness—Fluorouracil—skin cancer	0.000989	0.00104	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000983	0.00104	CcSEcCtD
Famotidine—Insomnia—Docetaxel—skin cancer	0.000976	0.00103	CcSEcCtD
Famotidine—Paraesthesia—Docetaxel—skin cancer	0.000969	0.00102	CcSEcCtD
Famotidine—Nausea—Temozolomide—skin cancer	0.000964	0.00102	CcSEcCtD
Famotidine—Somnolence—Docetaxel—skin cancer	0.00096	0.00101	CcSEcCtD
Famotidine—Vomiting—Fluorouracil—skin cancer	0.000951	0.001	CcSEcCtD
Famotidine—Dyspepsia—Docetaxel—skin cancer	0.00095	0.001	CcSEcCtD
Famotidine—Rash—Fluorouracil—skin cancer	0.000943	0.000995	CcSEcCtD
Famotidine—Dermatitis—Fluorouracil—skin cancer	0.000942	0.000995	CcSEcCtD
Famotidine—Decreased appetite—Docetaxel—skin cancer	0.000938	0.000991	CcSEcCtD
Famotidine—Headache—Fluorouracil—skin cancer	0.000937	0.000989	CcSEcCtD
Famotidine—Fatigue—Docetaxel—skin cancer	0.000931	0.000982	CcSEcCtD
Famotidine—Constipation—Docetaxel—skin cancer	0.000923	0.000974	CcSEcCtD
Famotidine—Pain—Docetaxel—skin cancer	0.000923	0.000974	CcSEcCtD
Famotidine—Feeling abnormal—Docetaxel—skin cancer	0.00089	0.000939	CcSEcCtD
Famotidine—Nausea—Fluorouracil—skin cancer	0.000888	0.000938	CcSEcCtD
Famotidine—Gastrointestinal pain—Docetaxel—skin cancer	0.000883	0.000932	CcSEcCtD
Famotidine—Abdominal pain—Docetaxel—skin cancer	0.000853	0.000901	CcSEcCtD
Famotidine—Body temperature increased—Docetaxel—skin cancer	0.000853	0.000901	CcSEcCtD
Famotidine—Hypersensitivity—Docetaxel—skin cancer	0.000795	0.00084	CcSEcCtD
Famotidine—Asthenia—Docetaxel—skin cancer	0.000774	0.000818	CcSEcCtD
Famotidine—Pruritus—Docetaxel—skin cancer	0.000764	0.000806	CcSEcCtD
Famotidine—Diarrhoea—Docetaxel—skin cancer	0.000739	0.00078	CcSEcCtD
Famotidine—Dizziness—Docetaxel—skin cancer	0.000714	0.000754	CcSEcCtD
Famotidine—Vomiting—Docetaxel—skin cancer	0.000686	0.000725	CcSEcCtD
Famotidine—Rash—Docetaxel—skin cancer	0.000681	0.000718	CcSEcCtD
Famotidine—Dermatitis—Docetaxel—skin cancer	0.00068	0.000718	CcSEcCtD
Famotidine—Headache—Docetaxel—skin cancer	0.000676	0.000714	CcSEcCtD
Famotidine—Nausea—Docetaxel—skin cancer	0.000641	0.000677	CcSEcCtD
